Anti-RHCE/ CD240CE/ RH monoclonal antibody

Anti-RHCE/ CD240CE/ RH antibody for FACS & in-vivo assay

Target products collectionGo to RHCE/RHCE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1463-Ab-1/ GM-Tg-hg-MP1463-Ab-2Anti-Human RHCE monoclonal antibodyHuman
GM-Tg-rg-MP1463-Ab-1/ GM-Tg-rg-MP1463-Ab-2Anti-Rat RHCE monoclonal antibodyRat
GM-Tg-mg-MP1463-Ab-1/ GM-Tg-mg-MP1463-Ab-2Anti-Mouse RHCE monoclonal antibodyMouse
GM-Tg-cynog-MP1463-Ab-1/ GM-Tg-cynog-MP1463-Ab-2Anti-Cynomolgus/ Rhesus macaque RHCE monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1463-Ab-1/ GM-Tg-felg-MP1463-Ab-2Anti-Feline RHCE monoclonal antibodyFeline
GM-Tg-cang-MP1463-Ab-1/ GM-Tg-cang-MP1463-Ab-2Anti-Canine RHCE monoclonal antibodyCanine
GM-Tg-bovg-MP1463-Ab-1/ GM-Tg-bovg-MP1463-Ab-2Anti-Bovine RHCE monoclonal antibodyBovine
GM-Tg-equg-MP1463-Ab-1/ GM-Tg-equg-MP1463-Ab-2Anti-Equine RHCE monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1463-Ab-1/ GM-Tg-hg-MP1463-Ab-2; GM-Tg-rg-MP1463-Ab-1/ GM-Tg-rg-MP1463-Ab-2;
GM-Tg-mg-MP1463-Ab-1/ GM-Tg-mg-MP1463-Ab-2; GM-Tg-cynog-MP1463-Ab-1/ GM-Tg-cynog-MP1463-Ab-2;
GM-Tg-felg-MP1463-Ab-1/ GM-Tg-felg-MP1463-Ab-2; GM-Tg-cang-MP1463-Ab-1/ GM-Tg-cang-MP1463-Ab-2;
GM-Tg-bovg-MP1463-Ab-1/ GM-Tg-bovg-MP1463-Ab-2; GM-Tg-equg-MP1463-Ab-1/ GM-Tg-equg-MP1463-Ab-2
Products NameAnti-RHCE monoclonal antibody
Formatmab
Target NameRHCE
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-RHCE benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species RHCE/ CD240CE/ RH VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1463
    Target NameRHCE
    Gene ID6006,100071320
    Gene Symbol and SynonymsCD240CE,RH,RH30,RH30A,Rh4,RHC,RHCE,RHCe(152N),RHD,RHE,RhIVb(J),RHIXB,RHNA,RHPI,RhVI,RhVIII
    Uniprot AccessionP18577
    Uniprot Entry NameRHCE_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000188672
    Target ClassificationN/A

    The target: RHCE, gene name: RHCE, also named as CD240CE, RH, RH30A, RHC, RHCe(152N), RHE, RHIXB, RHNA, RHPI, Rh4, RhIVb(J), RhVI, RhVIII. The Rh blood group system is the second most clinically significant of the blood groups, second only to ABO. It is also the most polymorphic of the blood groups, with variations due to deletions, gene conversions, and missense mutations. The Rh blood group includes this gene which encodes both the RhC and RhE antigens on a single polypeptide and a second gene which encodes the RhD protein. The classification of Rh-positive and Rh-negative individuals is determined by the presence or absence of the highly immunogenic RhD protein on the surface of erythrocytes. A mutation in this gene results in amorph-type Rh-null disease. Alternative splicing of this gene results in multiple transcript variants encoding several different isoforms. [provided by RefSeq, Aug 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.